Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-12

FDA Approved: VALGANCICLOVIR HYDROCHLORIDE — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for valganciclovir hydrochloride by NorthStar Rx LLC, enabling a generic valganciclovir product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valganciclovir hydrochloride (VALGANCICLOVIR HYDROCHLORIDE)

Snippet

SUPPL AP for VALGANCICLOVIR HYDROCHLORIDE (VALGANCICLOVIR HYDROCHLORIDE)